Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations

Nature Clinical Practice Oncology

Volumn 4, Issue 2, 2007, Pages 130-134

  Scott, Richard H ^a   Pritchard Jones, Kathryn ^b   Rahman, Nazneen ^c   Mansour, Sahar ^b   Kumar, Devinder ^b   MacSweeney, Fergus ^d  

^a Clinical Research Fellow in Cancer Genetics

^b Department of Childhood Cancer Biology ^*

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CAPECITABINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; PROTEIN MSH6; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADENOCARCINOMA; ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER GENETICS; CASE REPORT; COLON CARCINOMA; COLON RESECTION; COLONOSCOPY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; ENGRAFTMENT; FAMILY HISTORY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; IRRADIATION; MEDULLOBLASTOMA; MISMATCH REPAIR; MULTIPLE CYCLE TREATMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECTUM HEMORRHAGE; SKIN PIGMENTATION;

ADOLESCENT; CEREBELLAR NEOPLASMS; COLONIC NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MEDULLOBLASTOMA; PIGMENTATION DISORDERS;

EID: 33846660119     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0719     Document Type: Article

References (18)

1. Menko FH et al. (2004) A homozygous MSH6 mutation in a child with cafe-au-lait spots, oligodendroglioma and rectal cancer. Fam Cancer 3: 123-127
2. Hegde MR et al. (2005) A homozygous mutation in MSH6 causes Turcot syndrome. Clin Cancer Res 11: 4689-4693
3. Ostergaard JR et al. (2005) Neurofibromatosis von Recklinghausen type I phenotype and early onset of cancers in siblings compound heterozygous for mutations in MSH6. Am J Med Genet A 139:96-105
4. Plaschke J et al. (2006) Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without haematological malignancy and brain tumor. Eur J Hum Genet 14:561-566
5. Plaschke J et al. (2004) Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: The German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 22: 4486-4494
6. Wang Q et al. (1999) Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res 59: 294-297
7. DeBella K et al. (2000) Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 105: 608-614
8. Hamilton SR et al. (1995) The molecular basis of Turcot's syndrome. N Engl J Med 332: 839-847
9. Reid S et al. (2005) Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour. J Med Genet 42: 147-151
10. Bakhshi S et al. (2003) Medulloblastoma with adverse reaction to radiation therapy in nijmegen breakage syndrome. J Pediatr Hematol Oncol 25: 248-251
11. German J (1997) Bloom's syndrome. XX. The first 100 cancers. Cancer Genet Cytogenet 93: 100-106
12. National Comprehensive Cancer Network (2003) Colorectal cancer screening: Clinical practice guidelines in oncology. J Nat Comp Cancer Net 1: 72-93
13. Allan JM and Travis LB (2005) Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer 5: 943-955
14. Fedier A and Fink D (2004) Mutations in DNA mismatch repair genes: implications for DNA damage signaling and drug sensitivity. Int J Oncol 24: 1039-1047
15. Hunter C et al. (2006) A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. Cancer Res 66: 3987-3991
16. Fink D et al. (1998) Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin. Int J Cancer 77: 741-746
17. Offman J et al. (2004) Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. Blood 104: 822-828
18. Jover R et al. (2006) Mismatch repair status in prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut 55: 848-855